Buchi J Kevin's Form 4 filing

Ampio Pharmaceuticals, Inc. (AMPE) · filed May 16, 2023

Accession no.: 0001615594-23-000032
Filed: May 16, 2023, 3:30 PM ET
Trade date: May 12-15, 2023
Filing delay: 4 days
Rule 10b5-1 plan: Not checked

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market purchases total $16.4K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Buchi J KevinCIK 0001209726	Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
May 12, 2023	Common Stock	PPurchaseAcquired	+23,440	$0.2352^F1	+$5,513.09	23,440	Direct
May 15, 2023	Common Stock	PPurchaseAcquired	+44,026	$0.2466^F2	+$10,856.81	67,466	Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $0.228 to $0.244, inclusive.

Referenced by the price of 1 transaction in Table I.

The price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $0.227 to $0.2598, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)